Assessments of very low level HIV replication for dolutegravir plus lamivudine (DTG+3TC) vs dolutegravir plus tenofovir disoproxil/emtricitabine (DTG plus TDF/FTC) in the GEMINI 1&2 studies through week 96
HIV MEDICINE(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要